Displaying 701 - 720 of 2223
FTC Requests Rehearing En Banc of Qualcomm Appeals Panel Decision
FTC and DOJ Seek Comments on Proposed Amendments to HSR Rules and Advanced Notice of Proposed HSR Rulemaking
FTC to Host Virtual Workshop on Data Portability on September 22, 2020
FTC’s Bureau of Economics to Expand Merger Retrospective Program
International Competition Network Addresses Enforcement and Policy Challenges of the Digital Economy at United States-Hosted 19th Annual Conference
FTC Staff Submits Public Comment in Texas Opposing Certificate of Public Advantage Applications
FTC Staff Comment to Texas Health and Human Services Commission Regarding Certificate of Public Advantage Applications
FTC Staff Comment to Attorney General of Texas Concerning Certified Registered Nurse Anesthetists (CRNA) Regulations
FTC Comment to Texas Attorney General Raises Concerns about Likely Competitive Effect of Proposed Regulations Imposing Additional Supervisory Requirements on Texas Certified Nurse Anesthetists
Federal Trade Commission and U.S. Department of Justice Antitrust Division to Co-Host the 19th Annual International Competition Network Conference
FTC Approves Final Order Requiring Animal Health Product Suppliers Elanco Animal Health, Inc. and Bayer Animal Health GmbH to Divest Assets in Three Product Markets as a Condition of Acquisition
Elanco Animal Health and Bayer
In July 2020, the FTC required global suppliers of animal products, Elanco Animal Health, Inc. and Bayer Animal Health GmbH, to divest three animal health products to settle charges that Elanco’s proposed $7.6 billion acquisition of Bayer would likely be anticompetitive in those markets. On Sept. 11, 2020, the Commission announced the final consent agreement in this matter.
FTC Releases Agenda for September Workshop on Data Portability
FTC Approves Final Order Imposing Conditions on AbbVie Inc.’s Acquisition of Allergan plc
Federal Trade Commission and U.S. Department of Justice Antitrust Division to Co-Host the 19th Annual International Competition Network Conference
AbbVie Inc. and Allergan plc, In the Matter of
Pharmaceutical companies AbbVie Inc. and Allergan plc have agreed to divest assests to settle Federal Trade Commission charges that AbbVie's proposed $63 billion acquisition of Allergan would violate federal antitrust law. On Sept. 4, 2020, the Commission announced the final consent agreement in this matter.
FTC Chairman Joseph J. Simons Signs Antitrust Cooperation Framework with Australia, Canada, New Zealand, and United Kingdom
Displaying 701 - 720 of 2223